We are monitoring the impact of COVID-19 & Recession alarm on Latin America HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Latin America HIV Diagnostics Market Research Report - Segmented By Product, Type, End User & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 2056
Pages: 130

Latin America HIV Diagnostics Market Size (2022 to 2027):

As per the research report, the Latin America HIV Diagnostics Market size is valued at USD 462.84 million in 2022 and is estimated to be growing at a CAGR of 10.2% to reach 752.21 million by 2027 during the forecast period.

HIV/AIDS, also called a Human Immunodeficiency Virus or Acquired immunodeficiency syndrome, can be transmitted through contact with infected blood, vaginal fluids, and semen. Whereas the treatment can help, but this condition can't be cured and requires a medical diagnosis.

The driving factors contributing to the market's growth are a rise in disease prevalence and increased HIV patients. Latin America stands for technological improvements and advancements, and hence, the improved diagnostic tools increase market value. Increased adaption of home kits for testing blood for HIV also increased market value. Rapid assay tests, immunological tests are also responsible for accurate testing process for diagnosing HIV. Hence research and developments in this region through various government funds increase market size.

The strict rules and regulations for the ethical committee hamper the market growth. For the research and developments government releases funds; still, the expensive process for the same is back point for the market. High costs are associated with the process and tests like NAT (Nucleic acid testing). Lack of proper guidance and poor regulation also a turndown point for this market. 

During COVID 19, there are many travel ban issues and lockdown regulations to prevent the virus's spread. There is a lack of skilled workers and staff for various clinics, hospitals, and diagnostic centers. Hence this affected market in a huge scenario. The people who wanted to get tested could not get in touch with healthcare workers as they indulged in COVID healthcare schemes and regulations. 

This research report on the Latin America HIC Diagnostics Market has been segmented and sub-segmented into the following categories:

  • By Product: Consumables, Instruments, Software & Services                
  • By Type: Antibody Tests, Viral Identification Tests, CD4 Testing, Viral Load testing, Early Infant Diagnostics              
  • By End User: Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users             
  • By Country: Mexico, Brazil, Argentina, Chile and Rest of Latin America

Regionally, the Latin American market continues to grow steadily during the forecast period. Around 2.4 million people were reported with HIV in Latin America. Wherein Adult HIV Prevalence for age between 19 to 45 years is seen more. The awareness about HIV in people is impressive in Latin America that the people know their HIV status and receive treatment. In Caribbean countries, 11 out of 16 regions rely on funds from external sources such as charities, public, NGO'S, and Government. Also, the Caribbean is the second largest HIV prevalence region. 

Prominent companies leading in the Latin America HIV Diagnostics Market profiled in the report are Abbott Healthcare, Bristol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, BD Biosciences, Beckman Coulter, VIIV Healthcare, Partec, Sysmex, Apogee Flow Systems, Mylan inc., PointCare Technologies Inc., Zyomyx Inc., Qiagen, Siemens Healthcare, Roche Diagnostics, and bioMerieux.

1.Introduction           

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions 

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary 

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints     

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation                       

                5.1 Product 

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

5.1.2.1 Assays and Kits &Reagents                           

5.1.2.2 Other Consumables                        

                                5.1.3 Instruments                                           

                                5.1.4 Software & Services                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Type       

                                5.2.1 Introduction                                           

                                5.2.2 Antibody Tests                                      

5.2.2.1 HIV Screening Tests                         

         5.2.2.1.1 Elisa    

         5.2.2.1.2 Rapid Tests      

         5.2.2.1.3 Home Access Dried Blood Spots             

5.2.2.2 HIV-1 Antibody Confirmatory Tests                          

         5.2.2.2.1 Western Blot Tests       

         5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)      

         5.2.2.2.3 Line Immunoassays     

         5.2.2.2.4 Radio-Immunoprecipitation Assays      

5.2.2.3  HIV-2 & Group O Diagnostic Tests                            

         5.2.2.3.1 Blood Antibody Tests  

         5.2.2.3.2 DBS Tests         

         5.2.2.3.3 Line ImmunoAssay (HIV2)         

                                5.2.3 Viral Identification Tests                                    

5.2.3.1 p24 Antigen Test                               

5.2.3.2 Qualitative PCR Tests                      

5.2.3.3 Viral Culture                        

                                5.2.4 CD4 Testing                                             

                                5.2.5 Viral Load testing                                  

                                5.2.6 Early Infant Diagnostics                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                   

                                5.2.9 Market Share Analysis, By Type                                     

                5.3 End User       

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostic Laboratories                                     

                                5.3.3 Hospitals                                  

                                5.3.4 Blood Banks                                            

                                5.3.5 Home Care Settings                                            

                                5.3.6 Other End Users                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                          

                                5.3.9  Market Share Analysis, By End User                                            

6. Geographical Analysis                       

                6.1 Introduction        

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Product                           

6.1.3.3 By Type                 

6.1.3.4 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Product                           

6.1.4.3 By Type                 

6.1.4.4 By End User                        

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Product                           

6.1.5.3 By Type                 

6.1.5.4 By End User                        

                6.2 Brazil      

                6.3 Mexico  

                6.4 Rest of Latin America      

7.Strategic Analysis                 

                7.1 PESTLE analysis  

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis       

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                  

                8.1 Siemens Healthineers (A Division of Siemens AG)      

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)     

                8.3 Abbott Laboratories        

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)   

                8.5 Thermo-Fisher Scientific Inc.        

                8.6 Merck KGaA        

                8.7 Becton, Dickinson & Company    

                8.8 Hologic Inc.  

                8.9 Alere Inc.      

                8.10 Bio-Rad Laboratories     

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables 

                b) List of Figures       

  1. Latin America HIV Diagnostics Market, By Product, From 2022 - 2027 (USD Million)
  2. Latin America Consumables Market, By Region, From 2022 - 2027 (USD Million)
  3. Latin America Instruments Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Software & Services Market, By Region, From 2022 - 2027 (USD Million)
  5. Latin America HIV Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  6. Latin America Antibody Tests Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Viral Identification tests Market, By Region, From 2022 - 2027 (USD Million)
  8. Latin America CD4 Testing Market, By Region, From 2022 - 2027 (USD Million)
  9. Latin America Viral Load Testing Market, By Region, From 2022 - 2027 (USD Million)
  10. Latin America Early Infant Diagnosticss Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America HIV Diagnostics Market, By End-User, From 2022 - 2027 (USD Million)
  12. Latin America Diagnostic Labortaries Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  14. Latin America Blood Banks Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Home Care Settings Market, By Region, From 2022 - 2027 (USD Million)
  16. Latin America Other End Users Market, By Region, From 2022 - 2027 (USD Million)
  17. Brazil HIV Diagnostics Market, By Product, From 2022 - 2027 (USD Million)
  18. Brazil HIV Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  19. Brazil HIV Diagnostics Market, By End-User, From 2022 - 2027 (USD Million)
  20. Argentina HIV Diagnostics Market, By Product, From 2022 - 2027 (USD Million)
  21. Argentina HIV Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  22. Argentina HIV Diagnostics Market, By End-User, From 2022 - 2027 (USD Million)
  23. Mexico HIV Diagnostics Market, By Product, From 2022 - 2027 (USD Million)
  24. Mexico HIV Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  25. Mexico HIV Diagnostics Market, By End-User, From 2022 - 2027 (USD Million)
  26. Rest of Latin America HIV Diagnostics Market, By Product, From 2022 - 2027 (USD Million)
  27. Rest of Latin America HIV Diagnostics Market, By Type, From 2022 - 2027 (USD Million)
  28. Rest of Latin America HIV Diagnostics Market, By End-User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample